Immunotherapy of HLA [human leukocyte antigen]-A2 positive stage III/IV melanoma patients with CpG7909, tumor antigenic peptides and montanide
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Melanoma vaccine (Primary)
- Indications Malignant melanoma
- Focus Adverse reactions; Therapeutic Use
- 22 Apr 2013 Biomarkers information updated
- 27 Jun 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 09 Jun 2011 Planned end date changed from 1 Mar 2008 to 1 Jun 2012 as reported by ClinicalTrials.gov.